Drug profile · INN
paroxetine mesylate
PEXEVA
paroxetine mesylate (PEXEVA) is a serotonin transporter inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — paroxetine mesylate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
paroxetine mesylate (PEXEVA) is a serotonin transporter inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Serotonin transporter inhibitor
Primary target: Sodium-dependent serotonin transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is paroxetine mesylate?
paroxetine mesylate (PEXEVA) is a serotonin transporter inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for paroxetine mesylate?
PEXEVA is a marketed brand name for paroxetine mesylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of paroxetine mesylate?
paroxetine mesylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.